谷歌浏览器插件
订阅小程序
在清言上使用

Preliminary Results from an Ongoing Phase 2, Open-Label, Multicenter, Single-Arm Study Assessing an Every-4-Week Dosing Schedule of Mogamulizumab in Patients with Cutaneous T-Cell Lymphoma

J. Scarisbrick,C. Querfeld,O. Akilov,M. Bagot,R. Cordoba,R. Cowan, A. M. Garcia-Sancho,L. J. Geskin, A. O. Huen, J. Jadwani, Y. Liu, H. Zhao,S. Morris,P. L. Ortiz-Romero, A. Patel, L. C. Pinter-Brown,R. M. Pujol,P. Quaglino,N. S. Saba, R. Vuppugalla,Y. H. Kim

EUROPEAN JOURNAL OF CANCER(2024)

引用 0|浏览2
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要